Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Francis, C. W.
Right arrow Articles by Martin, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Francis, C. W.
Right arrow Articles by Martin, S. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Plasmic degradation of crosslinked fibrin. I. Structural analysis of the particulate clot and identification of new macromolecular-soluble complexes

CW Francis, VJ Marder and SE Martin

Plasmic degradation of crosslinked fibrin has been studied to identify the proteolytic cleavages that convert the clot into a soluble lysate and also to identify the derivatives that are likely to circulate during clot dissolution. Initial polypeptide chain cleavages do not disrupt the solid clot matrix. With continued exposure to plasmin, high molecular weight derivatives are produced that remain attached to the clot by noncovalent forces. Further degradation then results in the liberation into solution of several large, noncovalently bound complexes. Progressive degradation of the largest, initially liberated complexes to the terminal derivatives, DD/E, DD, and E, occurs in solution after their release from the clot. As the fibrin clot is exposed to plasmin for longer intervals, progressive dissolution occurs, but the structure of the covalently bound insoluble fibrin core, the noncovalently attached derivatives, and the liberated complexes remains constant. Since much of the initially liberated protein is in complexes larger than DD/E, these derivatives probably represent the more prevalent plasmic degradation products of crosslinked fibrin in vivo.

Volume 56, Issue 3, pp. 456-464, 09/01/1980
Copyright © 1980 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. H. Pospisil, A. R. Stafford, J. C. Fredenburgh, and J. I. Weitz
Evidence That Both Exosites on Thrombin Participate in Its High Affinity Interaction with Fibrin
J. Biol. Chem., June 6, 2003; 278(24): 21584 - 21591.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-F. Yan, J. Lu, Y. S. Zou, W. Kisiel, N. Mackman, M. Leitges, S. Steinberg, D. Pinsky, and D. Stern
Protein Kinase C-beta and Oxygen Deprivation. A NOVEL Egr-1-DEPENDENT PATHWAY FOR FIBRIN DEPOSITION IN HYPOXEMIC VASCULATURE
J. Biol. Chem., April 14, 2000; 275(16): 11921 - 11928.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Stewart, J. C. Fredenburgh, B. A. Leslie, B. A. Keyt, J. A. Rischke, and J. I. Weitz
Identification of the Mechanism Responsible for the Increased Fibrin Specificity of TNK-Tissue Plasminogen Activator Relative to Tissue Plasminogen Activator
J. Biol. Chem., March 31, 2000; 275(14): 10112 - 10120.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Kohno, K. Inuzuka, Y. Itoh, K. Nakahara, Y. Eguchi, T. Sugo, G. Soe, Y. Sakata, H. Murayama, and M. Matsuda
A monoclonal antibody specific to the granulocyte-derived elastase-fragment D species of human fibrinogen and fibrin: its application to the measurement of granulocyte-derived elastase digests in plasma
Blood, March 1, 2000; 95(5): 1721 - 1728.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. B. Walker and M. E. Nesheim
The Molecular Weights, Mass Distribution, Chain Composition, and Structure of Soluble Fibrin Degradation Products Released from a Fibrin Clot Perfused with Plasmin
J. Biol. Chem., February 19, 1999; 274(8): 5201 - 5212.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. I. Weitz, B. Leslie, and M. Hudoba
Thrombin Binds to Soluble Fibrin Degradation Products Where it Is Protected From Inhibition by Heparin-Antithrombin but Susceptible to Inactivation by Antithrombin-Independent Inhibitors
Circulation, February 17, 1998; 97(6): 544 - 552.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Asakura, K. Niwa, T. Tomozawa, Y.-m. Jin, S. Madoiwa, Y. Sakata, T. Sakai, H. Funayama, G. Soe, F. Forgerty, et al.
Fibroblasts Spread on Immobilized Fibrin Monomer by Mobilizing a beta 1-class Integrin, Together with a Vitronectin Receptor alpha vbeta 3 on Their Surface
J. Biol. Chem., March 28, 1997; 272(13): 8824 - 8829.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Okada, T. Fujita, K. Minamoto, H. Liao, Y. Naka, and D. J. Pinsky
Potentiation of Endogenous Fibrinolysis and Rescue from Lung Ischemia/Reperfusion Injury in Interleukin (IL)-10-reconstituted IL-10 Null Mice
J. Biol. Chem., July 7, 2000; 275(28): 21468 - 21476.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1980 by American Society of Hematology         Online ISSN: 1528-0020